NASDAQ:CTXR   Citius Pharmaceuticals, Inc.
If it falls to the resistance will buy again.
If not, will wait for consolidation.
First target at $6
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.